Supreme Court Dismisses Plea Challenging National HPV Vaccination Drive

The Supreme Court of India dismissed a Public Interest Litigation (PIL) that sought to challenge the national Human Papillomavirus (HPV) vaccination drive over allegations regarding the absence of informed consent protocols. A bench led by Justice Bagchi rejected the petition, stating that the World Health Organization (WHO) explicitly endorses the HPV vaccine as part of global preventive social medicine strategies, finding no lack of bonafide in government implementation.

Cervical cancer is the second most common cancer among women in India, primarily caused by persistent infection with high-risk types of HPV. The Government of India has been working toward integrating the HPV vaccine into the Universal Immunization Programme (UIP) for adolescent girls aged 9–14. Legal challenges questioning safety protocols or consent procedures have previously delayed public health initiatives, requiring clear judicial precedent to ensure uninterrupted implementation.

The Supreme Court observed that judicial intervention in standardized public health drives endorsed by authoritative global bodies like WHO must be exercise with restraint. The decision clears legal hurdles for national health agencies to proceed with mass immunization efforts aimed at immunizing millions of young girls against cervical cancer risk factors.

This judgment highlights the intersection of public health policy, fundamental rights under Article 21, and judicial restraint. Aspirants targeting UPSC GS Paper II (Governance & Health) and Law exams should note constitutional principles regarding public health administration and WHO guidelines on preventive vaccines.